NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-105-2018-0-EP-05 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data EP National Stage 19717657.1 Issued
NCI E-105-2018-0-GB-12 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data GB EP 19717657.1 Issued
NCI E-105-2018-0-IT-10 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data IT EP 19717657.1 Issued
NCI E-105-2018-0-CH-13 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data CH EP 19717657.1 Issued
NCI E-105-2018-0-ES-07 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data ES EP 19717657.1 Issued
NCI E-105-2018-0-DE-11 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data DE EP 19717657.1 Issued
NCI E-105-2018-0-DK-09 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data DK EP 19717657.1 Issued
NCI E-105-2018-0-FR-08 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data FR EP 19717657.1 Issued
NCI E-105-2018-0-NL-14 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data NL EP 19717657.1 Issued
NCI E-208-2015-0-US-09 THALIDOMIDE ANALOGS AND METHODS OF USE US CON 17/083,898 11440880 Issued PDF
NCI E-079-2020-2-PCT-01 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN PCT PCT COMB PCT/US2020/057949 Expired
NCI E-079-2020-2-EP-03 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN EP National Stage 20882104.1 Pending
NCI E-103-2021-0-EP-04 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS EP National Stage 19793684.2 Issued
NICHD E-138-2019-0-PCT-02 COMBINED PIKFYVE AND P38 MAP KINASE INHIBITION FOR TREATING CANCER PCT PCT PCT/US2020/057655 Expired
NCI E-103-2021-0-US-08 Use Of Lentivector - Transduced T-RAPA Cells For Amelioration Of Lysosomal Storage Disorders US National Stage 17/050,949 12239693 Issued PDF
NCI E-494-2013-0-MO-23 Methods of Preparing Anti-human Papillomavirus Antigen T Cells MO CN J/004455 Issued
NCI E-103-2021-0-JP-05 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS JP National Stage 2020-560341 Abandoned
NCI E-103-2021-0-SG-07 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS SG National Stage 11202010645V Abandoned
NCI E-253-2020-0-US-01 Single Domain Antibodies Targeting SARS-CoV-2 US 63/105,769 Abandoned
NCI E-094-2018-0-US-08 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF US National Stage 17/050,045 12415845 Issued PDF
NCATS E-193-2018-0-US-02 Improved CRISPR Therapy US National Stage 17/049,980 12152242 Issued PDF
NCI E-094-2018-0-JP-07 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF JP National Stage 2020-559481 Issued
NCATS E-244-2014-0-AU-10 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof AU DIV 2020257163 Issued
NIMH E-126-2018-0-US-03 NR2B LIGANDS; METHODS OF MAKING; AND USE THEREOF US National Stage 17/050,209 Abandoned
NIAID E-018-2018-0-IN-09 CHIMERIC VECTORS IN National Stage 202047046248 Pending
NIEHS E-125-2018-2-IL-04 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS IL National Stage 278246 Issued
NIAID E-018-2018-0-US-12 CHIMERIC VECTORS US National Stage 17/049,916 12071632 Issued PDF
NIAID E-018-2018-0-JP-10 CHIMERIC VECTORS JP National Stage 2020-558967 Issued
NIAID E-018-2018-0-BR-05 CHIMERIC VECTORS BR National Stage BR112020021652-6 Pending
NIAID E-018-2018-0-AU-04 CHIMERIC VECTORS AU National Stage 2019261570 Abandoned
NCI E-185-2019-0-JP-07 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors JP National Stage 2022-523456 Issued
NIAID E-288-2016-0-US-04 Biomarkers And Vaccine Candidates For Filarial Parasites US DIV 17/076,616 12251432 Issued PDF
NCI E-185-2019-0-CN-05 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors CN National Stage 202080074414.2 Issued
NCI E-185-2019-0-PCT-02 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors PCT PCT PCT/US2020/056601 Expired
NCI E-185-2019-0-EP-06 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors EP National Stage 20804404.0 Pending
NIAID E-220-2020-0-US-01 ANTIBODIES THAT NEUTRALIZE TYPE-I INTERFERON (IFN) ACTIVITY US 63/094,572 Abandoned
NCI E-185-2019-0-CA-04 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors CA National Stage 3156761 Pending
NCI E-185-2019-0-AU-03 High Affinity Nanobodies Targeting B7-H3 (CD276) For Treating Multiple Solid Tumors AU National Stage 2020370125 Pending
NIMH E-259-2016-0-US-05 RADIOLABELING AGENTS, METHODS OF MAKING, AND METHODS OF USE THEREOF US DIV 17/074,832 Abandoned
NIAID E-018-2018-0-CA-06 CHIMERIC VECTORS CA National Stage 3097888 Pending
NCI E-094-2018-0-CA-04 METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF CA National Stage 3097858 Pending
NCI E-036-2021-1-US-01 Autosomal Mosaicism Detected In Blood Cell DNA Of Healthy Individuals Predicts Post-cancer Diagnosis Infection Risk US 63/093,579 Abandoned
NIAID E-004-2022-0-US-01 Star Polymer Drug Conjugates US 63/093,445 Abandoned
NIAID E-031-2026-0-EP-01 Antigenic Epstein Barr Virus Polypeptides EP National Stage 19729869.8 Pending
NHGRI E-147-2020-0-US-01 High Concentration Methylcobalamin (Me-Cbl) Or Combination Of Methyl- And Hydroxocobalamin (Me/OH-Cbl) For The Treatment Of Cobalamin C Deficiency And Related Disorders US 63/093,084 Abandoned
NHGRI E-175-2019-0-PCT-02 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA PCT PCT PCT/US2020/055836 Expired
NIBIB E-007-2021-0-US-01 ANTIBODY SPECIFIC FOR SARS-COV-2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC
METHODS 		US 63/092,350 Abandoned
NCI E-028-2015-1-SA-37 T CELL RECEPTORS SPECIFIC FOR MUTATED KIRSTEN RAT SARCOMA VIRAL ONCOGENE HOMOLOG SA DIV 520420365 Pending
NCI E-097-2018-0-EP-08 ANTI-CD33 CHIMERIC ANTIGEN RECEPTORS AND THEIR USES EP National Stage 19714007.2 Pending
NIAID E-178-2019-0-US-01 STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS US 63/091,824 Abandoned